ArticleFrontiers in veterinary science2026
Medium and short chain fatty acid monoglycerides as an antibiotic alternative reduce diarrhea, improve growth, and modulate gut microbiota in weaned piglets.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the global post-antibiotic era, effective alternatives to in-feed antibiotics are urgently needed. This study evaluated a blend of natural molecules of monopropionin, monobutyrin, and monolaurin as an antibiotic alternative in weaned piglets. A total of 180 weaned piglets (Duroc × Landrace × Yorkshire; 24 ± 1 d) were randomly assigned to five dietary treatments for 42 days: control (CON, basal diet), antibiotic (ANTI, basal diet + 500 mg/kg enramycin), and three doses (T1: 600, T2: 1,000, T3: 1,400 mg/kg) of the blend. Growth performance, diarrhea incidence, serum biochemistry, immunity, nutrient digestibility, and fecal microbiota were assessed. Compared with CON, both ANTI and T2 significantly increased final body weight and average daily gain (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.